Zelda Therapeutics Ltd.
Company Description:
Zelda Therapeutics Limited (ASX:ZLD) (OTC:ZLDAF) is developing medicinal cannabis therapies in collaboration with a number of key international leaders and research organisations. Zelda has exclusive access to comprehensive patient data that has demonstrated therapeutic success using cannabinoid-based treatments and has leveraged this to commence pre-clinical research in breast, brain and pancreatic cancer and will commence human clinical trials in 2017 on a number of other disorders including insomnia and dermatological conditions such as eczema.